Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Raises $1M

NEW YORK (GenomeWeb News) – Privately-held US Genomics has raised $1 million through a sale of equity and debt securities to company executives and directors, and may raise up to $1 million more, according to a filing with the US Securities and Exchange Commission.

The Woburn, Mass.-based firm offers tools used in the extraction of high-grade DNA, tagging, microfluidics, and genomic mapping, for a range of purposes such as diagnostics, biosecurity, and food and drug monitoring.

In 2008, the firm reeled in a $4.5 million investment from Becton Dickinson as part of a collaborative agreement to develop molecular diagnostic technologies for human pathogens.

The company was not immediately available for comment to discuss its plans for the investment.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.